Abstract
Ischemic necrosis of surgical flaps after reconstruction is a major clinical problem. Hypoxia-inducible factor-1α (HIF-1α) is considered the master regulator of the adaptive response to hypoxia. Among its many properties, it regulates the expression of genes encoding angiogenic growth factors, which have a short half-life in vivo. To achieve a continuous application of the therapeutic, we utilized DNA plasmid delivery. Transcription of the DNA plasmid confirmed by qRT-PCR showed significantly increased mRNA for HIF-1α in the transfected tissue compared to saline control tissue. Rats were preconditioned by injecting with either HIF-1α DNA plasmid or saline intradermally in the designated flap region on each flank. Seven days after preconditioning, each rat had two isolated pedicle flaps raised with a sterile silicone sheet implanted between the skin flap and muscle layer. The flaps preconditioned with HIF-1α DNA plasmid had significantly less necrotic area. Angiogenesis measured by CD31 staining showed a significant increase in the number of vessels per high powered field in the HIF-1α group (p < 0.05). Our findings offer a potential therapeutic strategy for significantly promoting the viability of surgical pedicle flaps by ischemic preconditioning with HIF-1α DNA plasmid.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 2009;17:763–71.
Semenza GL. Life with oxygen. Science. 2007;318:62–64.
Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399–408.
Semenza GL. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta Mol Cell Res. 2011;1813:1263–8.
Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Science Signaling. 2005; 2005. https://doi.org/10.1126/stke.3062005re12.
Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721–32.
Liu L, Marti GP, Wei X, Zhang X, Zhang H, Liu YV, et al. Age-dependent impairment of HIF-1α expression in diabetic mice: correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells. J Cell Physiol. 2008;217:319–27.
Mitchell AC, Briquez PS, Hubbell JA, Cochran JR. Engineering growth factors for regenerative medicine applications. Acta Biomater. 2016;30:1–12. https://doi.org/10.1016/j.actbio.2015.11.007.
Yamakawa S, Hayashida K. Advances in surgical applications of growth factors for wound healing. Burns Trauma. 2019; 7. https://doi.org/10.1186/s41038-019-0148-1.
Lin MP, Marti GP, Dieb R, Wang J, Ferguson M, Qaiser R, et al. Delivery of plasmid DNA expression vector for keratinocyte growth factor-1 using electroporation to improve cutaneous wound healing in a septic rat model. Wound Repair Regen. 2006;14:618–24.
Semenza GL. Regulation of tissue perfusion in mammals by hypoxia-inducible factor 1. Exp Physiol. 2007;92:988–91.
Du J, Liu L, Lay F, Wang Q, Dou C, Zhang X, et al. Combination of HIF-1α gene transfection and HIF-1-activated bone marrow-derived angiogenic cell infusion improves burn wound healing in aged mice. Gene Therapy. 2013;20:1070–6.
Takaku M, Tomita S, Kurobe H, Kihira Y, Morimoto A, Higashida M et al. Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells. PLoS One. 2012; 7. https://doi.org/10.1371/journal.pone.0042964.
Mcfarlane RM, Deyoung G, Henry RA, Mcfarlane RM. The design of a pedicle flap in the rat to study necrosis and its prevention. Plastic Reconstruct Surg. 1965;35:177–82.
Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106:2781–6.
Zahir KS, Syed SA, Zink JR, Restifo RJ, Thomson GJ. Ischemic preconditioning improves the survival of skin and myocutaneous flaps in a rat model. Plastic Reconstruct Surg. 1998;102:140–50.
Derubertis BG. The elusive search for predictors of healing following transmetatarsal amputation. Arch Surg. 2011;146:1009.
Komorowski AL, Zanini V, Regolo L, Carolei A, Wysocki WM, Costa A. Necrotic complications after nipple- and areola-sparing mastectomy. World J Surg. 2006;30:1410–3.
Robertson S, Jeevaratnam J, Agrawal A, Cutress R. Mastectomy skin flap necrosis: challenges and solutions. Breast Cancer Targets Therapy. 2017;ume 9:141–52.
Patel KM, Hill LM, Gatti ME, Nahabedian MY. Management of massive mastectomy skin flap necrosis following autologous breast reconstruction. Ann Plast Surg. 2012;69:139–44.
Jensen JA, Lin JH, Kapoor N, Giuliano AE. Surgical Delay of the Nipple–Areolar Complex: A Powerful Technique to Maximize Nipple Viability Following Nipple-Sparing Mastectomy. Ann Surg Oncol. 2012;19:3171–6.
Little SC, Hughley BB, Park SS. Complications with forehead flaps in nasal reconstruction. Laryngoscope. 2009;119:1093–9.
Kroll SS. Necrosis of abdominoplasty and other secondary flaps after TRAM flap breast reconstruction. Plastic Reconstruct Surg. 1994;94:637–43.
Momeni A, Heier M, Bannasch H, Stark GB. Complications in abdominoplasty: a risk factor analysis. J Plastic Reconstruct Aesthet Surg. 2009;62:1250–4.
Wang HD, Singh DP. The use of indocyanine green angiography to prevent wound complications in ventral hernia repair with open components separation technique. Hernia. 2012;17:397–402.
Robertson JD, Torre JIDL, Gardner PM, Grant JH, Fix RJ, Vásconez LO. Abdominoplasty repair for abdominal wall hernias. Ann Plastic Surg. 2003;51:10–16.
Lance RH. Limb reconstruction versus amputation decision making in massive lower extremity trauma. Clin Orthop Rel Res. 1989; https://doi.org/10.1097/00003086-198906000-00014.
Hallock GG. Utility of both muscle and fascia flaps in severe lower extremity trauma. J Trauma Injury Infect Crit Care. 2000;48:913–7.
Parrett BM, Matros E, Pribaz JJ, Orgill DP. Lower extremity trauma: trends in the management of soft-tissue reconstruction of open tibia-fibula fractures. Plastic Reconstruct Surg. 2006;117:1315–22.
Odland RM, Kim P, Nadler D, Poole DV. Nonsurgical delay of skin flaps: effect of a suture delay technique on blood flow and survival. Laryngoscope. 1995;105:523–8.
Küntscher MV, Hartmann B, Germann G. Remote ischemic preconditioning of flaps: a review. Microsurgery. 2005;25:346–52.
Reichl H, Hladik M, Wechselberger G. Skin banking: treatment option for native skin necrosis following skin-sparing mastectomy and previous breast irradiation. Microsurgery. 2011;31:314–7.
Yessenow RS, Garner SL, Bauer CA, Kelly KM, Bardach J. The effects of calcium channel blockers on random skin flap survival in the pig model. Eur J Plastic Surg. 1991;14:3–6.
Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci. 1995;92:5510–4.
Hashimoto I, Takaku M, Matsuo S, Abe Y, Harada H, Nagae H, et al. Risk factors for complications after reconstructive surgery for sternal wound infection. Arch Plastic Surg. 2014;41:253.
Yager DR, Chen SM, Ward SI, Olutoye OO, Diegelmann RF, Cohen IK. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen. 1997;5:23–32.
Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, et al. Cell type–specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res. 2003;93:1074–81.
Wetterau M, George F, Weinstein A, Nguyen PD, Tutela JP, Knobel D, et al. Topical prolyl hydroxylase domain-2 silencing improves diabetic murine wound closure. Wound Repair Regen. 2011;19:481–6.
Kalucka J, Ettinger A, Franke K, Mamlouk S, Singh RP, Farhat K, et al. Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice. Mol Cell Biol. 2013;33:3426–38.
Schneider M, Harnoss JM, Strowitzki MJ, Radhakrishnan P, Platzer L, Harnoss JC et al. Therapeutic inhibition of prolyl hydroxylase domain-containing enzymes in surgery: putative applications and challenges. Hypoxia 2015;3:1–14.
Mace KA, Yu DH, Paydar KZ, Boudreau N, Young DM. Sustained expression ofHif-1αin the diabetic environment promotes angiogenesis and cutaneous wound repair. Wound Repair Regen. 2007;15:636–45.
Botusan IR, Sunkari VG, Savu O, Catrina AI, Grunler J, Lindberg S, et al. Stabilization of HIF-1 is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci. 2008;105:19426–31.
Duscher D, Januszyk M, Maan ZN, Whittam AJ, Hu MS, Walmsley GG et al. Comparison of the hydroxylase inhibitor dimethyloxalylglycine and the iron chelator deferoxamine in diabetic and aged wound healing. Plastic Reconstruct Surg. 2017; 139. https://doi.org/10.1097/prs.0000000000003072.
Duscher D, Neofytou E, Wong VW, Maan ZN, Rennert RC, Inayathullah M, et al. Transdermal deferoxamine prevents pressure-induced diabetic ulcers. Proc Natl Acad Sci. 2014;112:94–99.
Acknowledgements
Funding for this work was provided by the Hendrix Burn/Wound Fund, Johns Hopkins Bayview Medical Center, Johns Hopkins University.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
JWH, GPM, and FL are founders of Canton Biotechnologies Inc. (CBI), Baltimore, MD. CBI is a biotech company embedded in Johns Hopkins, founded to develop the plasmid DNA delivery of HIF for wound repair and regeneration.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Chang, KH., Shoureshi, P., Lay, F. et al. Preconditioning of surgical pedicle flaps with DNA plasmid expressing hypoxia-inducible factor-1α (HIF-1α) promotes tissue viability. Gene Ther 28, 319–328 (2021). https://doi.org/10.1038/s41434-020-00199-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41434-020-00199-6
This article is cited by
-
Transfection of hypoxia-inducible factor-1α mRNA upregulates the expression of genes encoding angiogenic growth factors
Scientific Reports (2024)
-
Progress in the study of mechanisms and pathways related to the survival of random skin flaps
Updates in Surgery (2024)